We are live on
!
Find out more
Asset Management One Portfolio holdings
AUM
$39B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.12%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.82%
5 Year Est. Return
+143.22%
10 Year Est. Return
+503.7%
AUM
$7.24B
AUM Growth
+$542M
(+8.1%)
Cap. Flow
+$601M
Cap. Flow
% of AUM
8.29%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
1,322
New
166
Increased
421
Reduced
404
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$23M |
| 2 |
Gilead Sciences
GILD
|
+$18.6M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$17.3M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$16.3M |
| 5 |
Biogen
BIIB
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$20M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$13.1M |
| 3 |
RTN
Raytheon Company
RTN
|
+$10.6M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$10.5M |
| 5 |
Regency Centers
REG
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 30.07% |
| 2 | Healthcare | 13.94% |
| 3 | Technology | 8.1% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
301
DELISTED
Chimerix, Inc.
CMRX
| $5.75M | 0.08% |
+199,325
| New | +$4.84M |
|
302
Baxter International
BAX
$13.8B
| $5.74M | 0.08% |
146,985
+1,662
| +1% | +$67.5K |
|
303
Henry Schein
HSIC
$9.7B
| $5.73M | 0.08% |
124,772
+96,059
| +335% | +$4.45M |
|
304
Texas Instruments
TXN
$255B
| $5.68M | 0.08% |
117,942
| – | – |
|
|
WLL
305
DELISTED
Whiting Petroleum Corporation
WLL
| $5.67M | 0.08% |
242
-3
| -1% | -$76.5K |
|
306
Salesforce
CRM
$148B
| $5.65M | 0.08% |
98,605
+20,475
| +26% | +$1.15M |
|
|
DTV
307
DELISTED
DIRECTV COM STK (DE)
DTV
| $5.62M | 0.08% |
64,923
-1,566
| -2% | -$135K |
|
308
Emerson Electric
EMR
$83.3B
| $5.62M | 0.08% |
89,654
-7,213
| -7% | -$468K |
|
309
Murphy Oil
MUR
$5.48B
| $5.58M | 0.08% |
98,032
+2,335
| +2% | +$145K |
|
310
Puma Biotechnology
PBYI
$402M
| $5.55M | 0.08% |
+22,403
| New | +$4.6M |
|
|
BNY
311
Bank of New York Mellon
BNY
$106B
| $5.54M | 0.08% |
143,594
+3,846
| +3% | +$150K |
|
|
HTWR
312
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $5.52M | 0.08% |
+69,555
| New | +$5.76M |
|
313
Oneok
OKE
$56.1B
| $5.52M | 0.08% |
83,710
+6,252
| +8% | +$419K |
|
314
Capri Holdings
CPRI
$1.82B
| $5.51M | 0.08% |
77,228
-1,540
| -2% | -$124K |
|
315
Crown Holdings
CCK
$12.9B
| $5.5M | 0.08% |
122,394
+24,891
| +26% | +$1.2M |
|
316
Morgan Stanley
MS
$330B
| $5.46M | 0.08% |
158,255
-8,100
| -5% | -$270K |
|
317
Warner Bros
WBD
$63.9B
| $5.46M | 0.08% |
144,396
+114,346
| +381% | +$4.76M |
|
318
Mettler-Toledo International
MTD
$27.9B
| $5.44M | 0.08% |
21,151
+17,762
| +524% | +$4.66M |
|
319
NiSource
NI
$21.6B
| $5.42M | 0.07% |
337,556
-201,707
| -37% | -$3.08M |
|
|
WFM
320
DELISTED
Whole Foods Market Inc
WFM
| $5.29M | 0.07% |
140,881
+29,677
| +27% | +$1.13M |
|
321
National Health Investors
NHI
$3.69B
| $5.27M | 0.07% |
91,364
-3,779
| -4% | -$234K |
|
|
CSG
322
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $5.27M | 0.07% |
696,933
-55,871
| -7% | -$438K |
|
|
COV
323
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $5.26M | 0.07% |
60,013
+1,344
| +2% | +$119K |
|
|
VIAB
324
DELISTED
Viacom Inc. Class B
VIAB
| $5.25M | 0.07% |
68,370
+8,636
| +14% | +$711K |
|
325
Liberty Global Class C
LBTYK
$3.49B
| $5.25M | 0.07% |
155,201
+20,087
| +15% | +$677K |
|
Similar funds
Asset Management One's Q3 2014 Portfolio in Review
As of Q3 2014, Asset Management One held 1,322 positions worth $7.24B, up 8.1% from $6.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Asset Management One deployed $601M of net new capital in Q3 2014, opening 166 new positions and adding to 421 existing holdings. Its largest new stake was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
By sector, the portfolio is most concentrated in Real Estate at 30% of assets, down from 34% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was American Tower, an estimated $20M trimmed.
- Asset Management One's largest Q3 2014 buy was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
- Asset Management One added most to AbbVie in Q3 2014, an estimated $23M increase.
- Asset Management One's biggest Q3 2014 reduction was American Tower, cutting an estimated $20M.
- Asset Management One fully exited Orbital ATK, Inc. in Q3 2014, selling an estimated $9.2M.
- Asset Management One's ten largest holdings make up 14% of its $7.24B portfolio in Q3 2014.
- Asset Management One opened 166 new positions and closed 77 in Q3 2014.
- Asset Management One's portfolio value rose 8.1% quarter-over-quarter to $7.24B.
Based on Asset Management One's 13F filing for Q3 2014, filed 5 Nov 2014.